61 related articles for article (PubMed ID: 30207790)
1. Prognostic Value of Volume-Based Metabolic Parameters of
Han S; Kim H; Kim YJ; Suh CH; Woo S
AJR Am J Roentgenol; 2018 Nov; 211(5):1112-1121. PubMed ID: 30207790
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.
Lin J; Xie G; Liao G; Wang B; Yan M; Li H; Yuan Y
Oncotarget; 2017 May; 8(20):33884-33896. PubMed ID: 27980228
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of posttreatment
Lima GM; Matti A; Vara G; Dondi G; Naselli N; De Crescenzo EM; Morganti AG; Perrone AM; De Iaco P; Nanni C; Fanti S
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2139-2146. PubMed ID: 30069578
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with renal carcinoma: A protocol for systematic review and meta analysis.
Xuan D; Wen W; Tian S; Piao M; Xu D; Liu L
Medicine (Baltimore); 2020 May; 99(20):e19988. PubMed ID: 32443301
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancer.
Michaan N; Wenkert A; Even-Sapir E; Kerzhner K; Rabin T; Safra T; Peleg-Hasson S; Baruch Y; Raz Y; Grisaru D; Laskov I
Int J Gynecol Cancer; 2023 Nov; 33(11):1695-1701. PubMed ID: 37657818
[TBL] [Abstract][Full Text] [Related]
6. Application of preoperative fluorodeoxyglucose-PET/CT parameters for predicting prognosis of high-grade neuroendocrine cervical cancer.
Song C; Lee JJ; Lee SH; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim JH
Nucl Med Commun; 2023 Nov; 44(11):1005-1010. PubMed ID: 37578339
[TBL] [Abstract][Full Text] [Related]
7. The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis.
Chen S; Tao M; Zhao L; Zhang X
Medicine (Baltimore); 2017 Oct; 96(40):e7981. PubMed ID: 28984757
[TBL] [Abstract][Full Text] [Related]
8. Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma.
Hong CM; Park SH; Chong GO; Lee YH; Jeong JH; Lee SW; Lee J; Ahn BC; Jeong SY
Cancer Imaging; 2019 Jun; 19(1):43. PubMed ID: 31234933
[TBL] [Abstract][Full Text] [Related]
9. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
Li K; Sun H; Guo Q
Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
[TBL] [Abstract][Full Text] [Related]
10.
Caresia-Aróztegui AP; Delgado-Bolton RC; Alvarez-Ruiz S; Del Puig Cózar-Santiago M; Orcajo-Rincon J; de Arcocha-Torres M; García-Velloso MJ;
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):59-68. PubMed ID: 30429069
[TBL] [Abstract][Full Text] [Related]
11. Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma-A Literature Review.
Molnar O; Straciuc OM; Mihuțiu S; Lazăr L
Curr Oncol; 2024 Apr; 31(5):2508-2526. PubMed ID: 38785469
[TBL] [Abstract][Full Text] [Related]
12. Overall survival and short-term efficacy analysis of cervical squamous cell carcinoma with skeletal muscle and
Zhang J; Niu S; Lu X; Hu R; Wu Z; Yang S; Liu H
Sci Rep; 2024 Feb; 14(1):4809. PubMed ID: 38413662
[TBL] [Abstract][Full Text] [Related]
13. Tumor and metastatic lymph nodes metabolic activity on
Song J; Pang W; Yi H; Ji J; Ye X; Li L
Abdom Radiol (NY); 2024 Mar; 49(3):975-984. PubMed ID: 38302763
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature.
Allahqoli L; Hakimi S; Laganà AS; Momenimovahed Z; Mazidimoradi A; Rahmani A; Fallahi A; Salehiniya H; Ghiasvand MM; Alkatout I
J Imaging; 2023 Oct; 9(10):. PubMed ID: 37888330
[TBL] [Abstract][Full Text] [Related]
15. Application of three-dimensional multi-imaging combination in brachytherapy of cervical cancer.
Zhang Z; Zhang N; Cheng G
Radiol Med; 2023 May; 128(5):588-600. PubMed ID: 37138200
[TBL] [Abstract][Full Text] [Related]
16. Repeatability of metabolic tumor burden and lesion glycolysis between clinical readers.
Choi JW; Dean EA; Lu H; Thompson Z; Qi J; Krivenko G; Jain MD; Locke FL; Balagurunathan Y
Front Immunol; 2023; 14():994520. PubMed ID: 36875072
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
Martinez A; Chantalat E; Angeles MA; Ferron G; Ducassou A; Daix M; Attal J; Bétrian S; Lusque A; Gabiache E
BMC Cancer; 2022 Jul; 22(1):810. PubMed ID: 35870900
[TBL] [Abstract][Full Text] [Related]
18. Influences on PET Quantification and Interpretation.
Rogasch JMM; Hofheinz F; van Heek L; Voltin CA; Boellaard R; Kobe C
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204542
[TBL] [Abstract][Full Text] [Related]
19. The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy.
Pedraza S; Seiffert AP; Sarandeses P; Muñoz-Lopez B; Gómez EJ; Sánchez-González P; Pérez-Regadera JF
Strahlenther Onkol; 2022 Sep; 198(9):792-801. PubMed ID: 35072751
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
